Research Catalogue

The Research Catalogue provides a comprehensive overview of research projects approved to use Breast Cancer Now Biobank specimens and the outputs generated from this work. Here, researchers can explore approved and ongoing projects, access associated publications and resources, and learn how Biobank-supported research is advancing breast cancer research.

190 to 198 of 344 results found
Publications XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib
Institution: University of Nottingham
Keyword(s): ATM, ATR, AZ31, AZD1775, AZD6738, DNA repair, PARP, Wee1, XRCC1, olaparib, synthetic lethality, triple negative breast cancer
Summary: PARP inhibitor (PARPi) monotherapy is a new strategy in BRCA germ-line deficient triple negative breast cancer (TNBC). However, not all patients respond, and the development of...
Year: 2020
Publications Are baseline ultrasound and mammographic features associated with rates of pathological completes response in patients receiving neoadjuvant chemotherapy for breast cancer?
Institution: University of Dundee
Keyword(s): mammography, neoadjuvant chemotherapy, pathological complete response, ultrasound
Summary: BACKGROUND. Increasing numbers of breast cancer patients receive neoadjuvant chemotherapy (NACT). We seek to investigate whether baseline mammographic and ultrasound features ar...
Year: 2019
Publications Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma
Institution: Peter MacCallum Cancer Centre; University of Melbourne
Keyword(s): -
Summary: The current model for breast cancer progression proposes independent 'low grade (LG)-like' and 'high grade(HG)-like' pathways but lacks a known precursor to HG cancer. We applie...
Year: 2019